Dr. Vladimir Kramskiy is board certified in neurology and pain medicine. As Director of the Ambulatory Recuperative Pain Medicine Program, he uses a comprehensive approach to treat acute and chronic spine and musculoskeletal pain, neuropathic pain, headaches and complex regional pain syndromes. His clinical goal is to restore optimal physical function by developing an individualized treatment plan for his patients.
Dr. Kramskiy specializes in minimally invasive fluoroscopically guided diagnostic and therapeutic procedures of the spine, such as epidural steroid injections, facet joint injections and discography, as well as advanced interventional methods such as radiofrequency neuroablation and implanted spinal cord stimulators. He is also skilled in botox injections for migraine pain. Dr. Kramskiy is also trained in dorsal root ganglion (DRG) stimulation, a novel treatment aimed at improving symptoms of chronic regional pain syndrome.
After earning his medical degree from Mount Sinai School of Medicine, Dr. Kramskiy completed a neurology residency at North Shore-Long Island Jewish Health System and a Pain and Palliative Care fellowship at Memorial Sloan Kettering Cancer Center. He then continued his training through the Tri-Institutional Pain Medicine fellowship at Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center and Hospital for Special Surgery, where he served as a chief fellow.
Acute and Chronic Spine and Musculoskeletal Pain
Diagnostic and Therapeutic Spinal Injection Procedures
Tension and Cluster Headache
Complex Regional Pain Syndrome
Phantom Limb Pain
Central Post Stroke Pain
Diagnostic and Therapeutic Spinal Injections
Advanced Interventional Neurolysis and Radiofrequency Neuroablation
Diagnostic Discography and Minimally Invasive Intradiscal Techniques
Implantation of Spinal Cord Stimulators
Botox Injections for the Treatment of Migraine
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Assistant Attending Physician in Anesthesiology, Hospital for Special Surgery
Clinical Assistant Professor of Anesthesiology, Weill Cornell Medical College
American Pain Society
American Society of Interventional Pain Physicians
American Academy of Neurology
Board Certified in Neurology, Board Certified in Pain Medicine
Castle Connolly Top Doctor, 5 Years
Castle Connolly Regional Top Doctor, 2016-2020
Castle Connolly Top Doctors in New York Metro Area, 2016-2022
New York Magazine Top Doctors, 2017-2022
Mount Sinai School of Medicine, New York, NY
Internal Medicine - Mount Sinai School of Medicine, Englewood Medical Center, NJ
Neurology - North-Shore Long Island Jewish Health System, New Hyde Park, NY
Pain and Palliative Care - Memorial Sloan-Kettering Cancer Center
Pain Medicine - Tri-Institutional Pain Medicine fellowship, Chief Fellow, Weill Cornell Medical Center, Memorial Sloan-Kettering Cancer Center and Hospital for Special Surgery
English, Russian by physician, Spanish by office staff
Faskowitz A, Kramskiy V, Pasternak G. Methadone-Induced Hypoglycemia Mouse Model. American Neurologic Association Annual Meeting. 2009.
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of April 19, 2023, Dr. Kramskiy reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.